In a nutshell This phase 1b/2 trial will investigate the safety of RMC-4630 and cobimetinib (Cotellic) in relapsed or unresponsive solid tumors. The main outcomes will be the number of side effects and the overall response rate. This trial is recruiting in a number of US states. The details Relapsed/refractory (R/R) cancer is a term for...
Read More
Home »
Non-small cell lung carcinoma genotype(s)-BRAF
Non-small cell lung carcinoma genotype(s)-BRAF Posts on Medivizor
To receive all the
cutting-edge updates personally relevant to you
(free and private)
Categories
- Benign prostatic hyperplasia
- Blog
- Breast cancer
- Colorectal cancer
- Coronary artery disease
- Coronavirus / COVID-19
- Diabetes mellitus
- Erectile dysfunction
- Hodgkin's lymphoma
- Hypertension
- Infertility
- Kidney stones
- Leukemia
- Lung cancer
- Lymphoma
- Melanoma
- Multiple Myeloma
- Nocturia
- Non-Hodgkin lymphoma
- Overactive bladder
- Parkinson's Disease
- Prostate cancer
- Rheumatoid Arthritis
- Stroke
- Urinary incontinence
- Urinary tract infection
Recent Posts
- Evaluating the effects of dance style and training duration in improving balance in patients with Parkinson’s disease.
- Evaluating the effectiveness and safety of immune checkpoint inhibitors given before surgery for the treatment of resectable mucosal melanoma.
- Comparing the effectiveness and safety of chemotherapy-based combination therapies as first-line treatment for advanced non-small cell lung cancer with negative PD-L1.
- Evaluating the effectiveness and safety of TAS-102 plus Yttrium-90 radioembolization for the treatment of patients with colorectal cancer liver metastasis.
- Evaluating the effectiveness of antibiotic bone cement for infected diabetic foot wounds
